Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants

Scientific Reports(2022)10.1038/s41598-022-06629-2Source: DataRank Database

mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants is a research paper published in Scientific Reports (2022). On theSindex it has a DataRank of 0. It has been cited 44 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access44 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 4.25)OA: goldTopics (36)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Dominic Esposito ORCID,Zhigang Kang ORCID,Jianming Lü ORCID,Alan T. Remaley ORCID,Valeria De Giorgi ORCID

Live enrichment

PubMed:35173254 PMC:PMC8850441 OpenAlex:https://openalex.org/W4226035586

CCR NIH HHS

Grant: HHSN261200800001C

NCI NIH HHS

Grant: HHSN261200800001E

National Institutes of Health

National Cancer Institute

NIH Clinical Center

National Heart, Lung, and Blood Institute

FWCI

4.25

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://www.nature.com/articles/s41598-022-06629-2.pdf

publisherhttps://www.nature.com/articles/s41598-022-06629-2.pdf

publisherhttps://www.nature.com/articles/s41598-022-06629-2

journalhttps://doi.org/10.1038/s41598-022-06629-2

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35173254

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testingAngiotensin-Converting Enzyme 2COVID-19COVID-19 VaccinesHumansNeutralization TestsSARS-CoV-2Spike Glycoprotein, CoronavirusmRNA VaccinesSARS-CoV-2 variants

MeSH Terms

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2COVID-19 VaccinesmRNA VaccinesHumansNeutralization TestsSpike Glycoprotein, Coronavirus

Keywords

NeutralizationAntibodyVirologyNeutralizing antibodyVaccinationImmunityBiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)ImmunologyAntiserumImmune systemCoronavirus disease 2019 (COVID-19)MedicineInfectious disease (medical specialty)DiseaseInternal medicine

Sustainable Development Goals

SDG 0: Good health and well-being

mRNA vaccine-induced antibodies more effective than natural immunity in neutralizing SARS-CoV-2 and its high affinity variants

FAIR Checklist

Authors (9)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)